Progress in the study of mitochondrial dysfunction in pathogenesis of amyotrophic lateral sclerosis

doi:10.16352/j.issn.1001-6325.2023.02.332

Abstract

Abstract: Mitochondrial dysfunction plays an important role in the pathogenesis of amyotrophic lateral sclerosis(ALS). The mitochondrial dysfunction will cause severe oxidative stress and disruption in calcium homeostasis. The abnormally released mitochondrial DNA will induce cellular inflammation. These phenomena may explain the loss of motor neurons in ALS patients. As a quality control process, either abnormal increased or decreased mitophagy flux will speed up the pathogenic development of ALS.

Key words: amyotrophic lateral sclerosis, mitochondrial dysfunction

CLC Number:

R741.02

LIU Liyang, LIU Qing, LIU Yaping, ZHANG Xue. Progress in the study of mitochondrial dysfunction in pathogenesis of amyotrophic lateral sclerosis[J]. Basic & Clinical Medicine, 2023, 43(2): 332-335.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.02.332

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I2/332

References 25

[1]	Mifflin L, Hu Z, Dufort C, et al. A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis[J]. Proc Natl Acad Sci U S A, 2021, 118: e2025102118. doi: 10.1073/pnas.2025102118.
[2]	Deng Z, Lim J, Wang Q, et al. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway[J]. Autophagy, 2020, 16: 917-931. doi: 10.1080/15548627.2019.1644076.
[3]	Marmor-Kollet H, Siany A, Kedersha N, et al. Spatiotemporal proteomic analysis of stress granule disassembly using APEX reveals regulation by SUMOylation and links to ALS pathogenesis[J]. Mol Cell, 2020, 80: 876-891 e6. doi: 10.1016/j.molcel.2020.10.032.
[4]	Bharath LP, Agrawal M, McCambridge G, et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation[J]. Cell Metab, 2020, 32: 44-55 e6. doi: 10.1016/j.cmet.2020.04.015.
[5]	Singh T, Jiao Y, Ferrando LM, et al. Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated[J]. Sci Rep, 2021, 11: 18916. doi: 10.1038/s41598-021-97928-7.
[6]	Hor JH, Santosa MM, Lim VJW, et al. ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation[J]. Cell Death Differ, 2021, 28: 1379-1397. doi: 10.1038/s41418-020-00664-0.
[7]	Sassani M, Alix JJ, McDermott CJ, et al. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis[J]. Brain, 2020, 143: 3603-3618. doi: 10.1093/brain/awaa340.
[8]	Cheong A, Archambault D, Degani R, et al. Nuclear-encoded mitochondrial ribosomal proteins are required to initiate gastrulation[J]. Development, 2020, 147: dev188714. doi: 10.1242/dev.188714.
[9]	Wynne ME, Lane AR, Singleton KS, et al. Heterogene-ous expression of nuclear encoded mitochondrial genes distinguishes inhibitory and excitatory neurons[J]. eNeuro, 2021, 8: ENEURO.0232-21.2021. doi: 10.1523/ENEURO.0232-21.2021.
[10]	Altman T, Ionescu A, Ibraheem A, et al. Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins[J]. Nat Commun, 2021, 12: 6914. doi: 10.1038/s41467-021-27221-8.
[11]	Mao F, Robinson JL, Unger T, et al. TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy[J]. Acta Neuropathol, 2021, 142: 629-642. doi: 10.1007/s00401-021-02330-2.
[12]	Zuo X, Zhou J, Li Y, et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS[J]. Nat Struct Mol Biol, 2021, 28: 132-142. doi: 10.1038/s41594-020-00537-7.
[13]	DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS[J]. Neuron, 2011, 72: 245-56. doi: 10.1016/j.neuron.2011.09.011.
[14]	Mehta AR, Gregory JM, Dando O, et al. Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis[J]. Acta Neuropathol, 2021, 141: 257-279. doi: 10.1007/s00401-020-02252-5.
[15]	Liu Y, Wang T, Ji YJ, et al. A C9orf72-CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stress[J]. Genes Dev, 2018, 32: 1380-1397. doi: 10.1101/gad.315564.118.
[16]	Wang T, Liu H, Itoh K, et al. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly[J]. Cell Metab, 2021, 33: 531-546 e9. doi: 10.1016/j.cmet.2021.01.005.
[17]	Nahm M, Lim SM, Kim YE, et al. ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics[J]. Sci Transl Med, 2020, 12: eaax3993. doi: 10.1126/scitranslmed.aax3993.
[18]	Dafinca R, Barbagallo P, Farrimond L, et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD[J]. Stem Cell Reports, 2020, 14: 892-908. doi: 10.1016/j.stemcr.2020.03.023.
[19]	Mccauley ME, O’Rourke JG, Yáñez A, et al. C9orf72 in myeloid cells suppresses STING-induced inflammation[J]. Nature, 2020, 585: 96-101. doi: 10.1038/s41586-020-2625-x.
[20]	Yu CH, Davidson S, Harapas CR, et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS[J]. Cell, 2020, 183: 636–649. doi: 10.1016/j.cell.2020.09.020.
[21]	Wang W, Arakawa H, Wang L, et al. Motor-coordinative and cognitive dysfunction caused by mutant TDP-43 could be reversed by inhibiting its mitochondrial localization[J]. Mol Ther, 2017, 25: 127-139. doi: 10.1016/j.ymthe.2016.10.013.
[22]	Tak YJ, Park JH, Rhim H, et al. ALS-related mutant SOD1 aggregates interfere with mitophagy by sequestering the autophagy receptor optineurin[J]. Int J Mol Sci, 2020, 21: 7525. doi: 10.3390/ijms21207525.
[23]	Harding O, Evans CS, Ye J, et al. ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy[J]. Proc Natl Acad Sci U S A, 2021, 118: e2025053118. doi: 10.1073/pnas.2025053118.
[24]	Maestro I, De La Ballina LR, Porras G, et al. Discovery of mitophagy inhibitors with therapeutic potential in different familial amyotrophic lateral sclerosis mutations[J]. Int J Mol Sci, 2022, 23: 12676. doi: 10.3390/ijms232012676.
[25]	Perera ND, Tomas D, Wanniarachchillage N, et al. Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice[J]. Neurobiol Dis, 2021, 154: 105359. doi: 10.1016/j.nbd.2021.105359.